Folgen
David Kleiner
David Kleiner
National Cancer Institute
Bestätigte E-Mail-Adresse bei mail.nih.gov
Titel
Zitiert von
Zitiert von
Jahr
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ...
Hepatology 41 (6), 1313-1321, 2005
110252005
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
AJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...
New England Journal of Medicine 362 (18), 1675-1685, 2010
38422010
Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease
P Angulo, DE Kleiner, S Dam-Larsen, LA Adams, ES Bjornsson, ...
Gastroenterology 149 (2), 389-397. e10, 2015
29432015
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
28032020
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
BA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...
The Lancet 385 (9972), 956-965, 2015
24822015
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
20022017
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
K Promrat, DE Kleiner, HM Niemeier, E Jackvony, M Kearns, JR Wands, ...
Hepatology 51 (1), 121-129, 2010
16602010
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial
JE Lavine, JB Schwimmer, ML Van Natta, JP Molleston, KF Murray, ...
Jama 305 (16), 1659-1668, 2011
13432011
Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
EM Brunt, DE Kleiner, LA Wilson, P Belt, BA Neuschwander‐Tetri, ...
Hepatology 53 (3), 810-820, 2011
13362011
Quantitative zymography: detection of picogram quantities of gelatinases
DE Kleiner, WG Stetlerstevenson
Analytical biochemistry 218 (2), 325-329, 1994
12321994
Matrix metalloproteinases and metastasis
DE Kleiner, WG Stetler-Stevenson
Cancer chemotherapy and pharmacology 43, S42-S51, 1999
11451999
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
K Promrat, G Lutchman, GI Uwaifo, RJ Freedman, A Soza, T Heller, E Doo, ...
Hepatology 39 (1), 188-196, 2004
10132004
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte–associated antigen 4
KE Beck, JA Blansfield, KQ Tran, AL Feldman, MS Hughes, RE Royal, ...
Journal of Clinical Oncology 24 (15), 2283-2289, 2006
9462006
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
HS Kuehn, W Ouyang, B Lo, EK Deenick, JE Niemela, DT Avery, ...
Science 345 (6204), 1623-1627, 2014
9122014
Endpoints and clinical trial design for nonalcoholic steatohepatitis
AJ Sanyal, EM Brunt, DE Kleiner, KV Kowdley, N Chalasani, JE Lavine, ...
Hepatology 54 (1), 344-353, 2011
8622011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
ME Rinella, BA Neuschwander-Tetri, MS Siddiqui, MF Abdelmalek, ...
Hepatology 77 (5), 1797-1835, 2023
8612023
Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease
K De
Hepatology 41, 1313-1321, 2005
8492005
Early-onset stroke and vasculopathy associated with mutations in ADA2
Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ...
New England Journal of Medicine 370 (10), 911-920, 2014
8352014
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis
WG Stetler‐Stevenson, LA Liotta, DE Kleiner Jr
The FASEB Journal 7 (15), 1434-1441, 1993
8261993
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
AG Duffy, SV Ulahannan, O Makorova-Rusher, O Rahma, H Wedemeyer, ...
Journal of hepatology 66 (3), 545-551, 2017
7942017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20